Etiological features of liver involvement in rheumatoid arthritis.
Liver involvement is not considered a typical extra-articular manifestation and has rarely been studied in rheumatoid arthritis (RA).We aimed to identify the prevalence and the aetiologies of liver disease in RA patients. A cross-sectional study included 150 patients with RA enrolled over a 5-year period (2010-2015). The clinical and paraclinical features of RA were analysed. The clinical and biological characteristics of liver impairment and its aetiologies were collected. One hundred fifty RA patients (124 women) with a mean age of 57.09 years and a mean RA duration of 7.52 years were included. Liver involvement was diagnosed in 66 patients (44%). The liver disease was asymptomatic in 94% of cases, revealed by increased gamma glutamyl transferase levels in 74% of patients. The aetiologies of liver involvement were hepatotoxicity of medications in 38 cases (57%), hepatitis B and C in 14 patients (21%), fatty liver disease in 10 cases (15%), autoimmune liver disease in 2 patients (3%), hydatid cyst in 1 case (2%), and liver angiomas in 1 case (2%). Non-steroidal anti-inflammatory drugs and methotrexate were the drugs most often involved in the genesis of hepatotoxicity (21% and 20% of cases, respectively). Liver involvement occurred in 44% of RA patients. Aetiologies were mainly hepatotoxicity and viral hepatitis B and C. Patients with RA should be systematically screened for liver disease, which is rarely symptomatic.